Billions Co.,Ltd.

As of March 31, 2026, Billions Co.,Ltd. carries a market capitalization of 125.84B, placing it among publicly traded companies globally. Its enterprise value stands at 129.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Billions Co.,Ltd. has 16.13M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 1.67, and the price-to-book ratio stands at 5.95.

As of March 31, 2026, Billions Co.,Ltd. trades at an EV/EBITDA multiple of 98.30 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.56 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 129.56B versus a market cap of 125.84B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Billions Co.,Ltd. maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 64.07, indicating elevated leverage, while an interest coverage ratio of 0.50 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Billions Co.,Ltd. posted a negative return on equity (ROE) of -28.04, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -13.20, reflecting losses generated across the asset base. The company generates approximately 328.37M in revenue per employee across its workforce of 86.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 8.48 indicates how many times Billions Co.,Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, Billions Co.,Ltd.'s stock has declined approximately 69.57% over the past 52 weeks. The 50-day moving average sits at 3,636.50, while the 200-day moving average is 5,994.70.

Over the twelve months ended March 31, 2026, Billions Co.,Ltd. generated 28.40B in revenue and converted that into -5.71B in net income, yielding earnings per share of -960.92. EBITDA reached 1.32B, while operating income came in at -85.91M.

As of March 31, 2026, Billions Co.,Ltd. holds 9.81B in cash and equivalents against 13.54B in total debt, resulting in a net debt position of 3.03B. Total book value stands at 21.13B, with working capital of -3.22B providing operational flexibility.

Billions Co.,Ltd. produced 1.04B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -129.72M in capital expenditures, free cash flow totaled 913.71M - equivalent to 149.99 per share.

Over the twelve months ended March 31, 2026, Billions Co.,Ltd. posted a gross margin of 20.12, reflecting its pricing power and cost economics. The operating margin of -0.30 and net profit margin of -20.11 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 1.92, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -5.28, meaning Billions Co.,Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Billions Co.,Ltd.'s most recent stock split took place on September 8, 2026 with a 5:1 split ratio.

As of March 31, 2026, Billions Co.,Ltd. has an Altman Z-Score of 1.24, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.